Delivery Order SPE2DB20D3505-SPE2DB25FYCSX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,768.30 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a non-set-aside, competitively awarded delivery order with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count supply) valued at $17,735.23. This firm fixed-price contract, awarded on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count) under a firm fixed price contract. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement and is issued as a child contract under...
- The Defense Logistics Agency awarded a $3,189.37 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ELIQUIS 2.5 mg tablets (60-count units). This firm fixed-price contract, which will be completed by September 16, 2025, is classified as a non-set-aside award and represents a single delivery order under the company's existing blanket purchasing agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $25,763.39. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,649.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with the DLA. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) with a ceiling value of $3,931.20. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract is executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $36,722.05. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on August 12, 2025, with completion scheduled for August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCSXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 2.5 mg tablets in a 60-count package, valued at $1,474.20 under a firm fixed-price contract. This non-set-aside award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this strategic contract vehicle, the company supplies critical medications, vaccines, and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/23/25 |